A new integrative approach combining right heart catheterization and echocardiography to stage aortic stenosis-related cardiac damage.

TAVR aortic stenosis echocardiography right heart catheterization staging

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2023
Historique:
received: 11 03 2023
accepted: 13 07 2023
medline: 21 8 2023
pubmed: 21 8 2023
entrez: 21 8 2023
Statut: epublish

Résumé

Although staging of the extent of aortic stenosis (AS)-related cardiac damages is usually performed via echocardiography, this technique has considerable limitations in assessing pulmonary artery and right chamber pressures. The present hypothesis-generating study sought to explore the efficacy of a staging system of cardiac damage based on echocardiographic and invasive [right heart catheterization (RHC)] hemodynamic parameters in patients undergoing transcatheter aortic valve implantation (TAVI). We studied 90 symptomatic patients with severe AS in whom echocardiographic and invasive evaluation by RHC was obtained prior to TAVI. Cardiac damage stages were defined as follows: no cardiac damage (stage 0), left ventricular (LV) damage (stage 1), left atrial or mitral valve damage (stage 2), pulmonary vasculature or tricuspid valve damage (stage 3), and right ventricular (RV) dysfunction or low-flow state (stage 4). With the integrative approach using RHC, pulmonary hypertension (PH) was defined as an mPAP ≥25 mmHg and the low-flow state corresponded to a cardiac index of <1.8 L/min/m During follow-up (median: 2.9 years), 43 patients (47.8%) died. The integrative cardiac damage staging was associated with a significant increase in all-cause and cardiovascular mortality per each increase of cardiac damage stage, whereas the outcome was similar according to the echocardiographic staging. A staging system of cardiac lesion based on echocardiographic and invasive hemodynamic parameters in patients with severe AS undergoing TAVI predicts mortality. Patients with pre-existing PH, ≥ moderate tricuspid regurgitation and/or RV dysfunction, and a low-flow state had a markedly increased risk of death. Further larger studies are needed to validate our findings.

Identifiants

pubmed: 37600042
doi: 10.3389/fcvm.2023.1184308
pmc: PMC10436206
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1184308

Informations de copyright

© 2023 Viva, Postolache, Nguyen Trung, Danthine, Petitjean, Bruno, Martinez, Lempereur, Guazzi, Aghezzaf, Coisne, Oury, Dulgheru and Lancellotti.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

JACC Cardiovasc Imaging. 2015 Jan;8(1):83-99
pubmed: 25592699
J Am Coll Cardiol. 2019 Jul 30;74(4):550-563
pubmed: 31345430
JAMA Cardiol. 2019 Mar 1;4(3):215-222
pubmed: 30725109
Lancet. 2003 Apr 12;361(9365):1241-6
pubmed: 12699950
J Am Coll Cardiol. 2019 Jul 30;74(4):538-549
pubmed: 31345429
Clin Geriatr Med. 2016 May;32(2):305-14
pubmed: 27113148
JACC Cardiovasc Interv. 2019 Nov 11;12(21):2155-2168
pubmed: 31699377
J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8
pubmed: 20620859
Can J Cardiol. 2020 Oct;36(10):1667-1674
pubmed: 32416065
J Am Coll Cardiol. 2002 Aug 21;40(4):789-95
pubmed: 12204512
Eur Heart J. 2017 Dec 01;38(45):3351-3358
pubmed: 29020232
JACC Cardiovasc Interv. 2019 Nov 11;12(21):2145-2154
pubmed: 31699376
J Am Soc Echocardiogr. 2016 Apr;29(4):277-314
pubmed: 27037982
Eur Heart J Qual Care Clin Outcomes. 2021 Oct 28;7(6):532-541
pubmed: 34086888
Rev Esp Cardiol (Engl Ed). 2016 Feb;69(2):177
pubmed: 26837729
Eur Heart J. 2018 Jul 21;39(28):2659-2667
pubmed: 29741615
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
Eur Heart J. 2022 Feb 12;43(7):561-632
pubmed: 34453165
JACC Cardiovasc Interv. 2019 Nov 11;12(21):2169-2172
pubmed: 31699378
Eur Heart J. 2022 Oct 11;43(38):3618-3731
pubmed: 36017548

Auteurs

Tommaso Viva (T)

GIGA Cardiovascular Sciences, CHU Sart Tilman, Cardiology Department, University of Liège Hospital, Liège, Belgium.
Department of Biomedical Sciences for Health, University of Milano, Milan, Italy.
Department of Minimally Invasive Cardiac Surgery, IRCCS Galeazzi-Sant'Ambrogio Hospital, Milan, Italy.

Adriana Postolache (A)

GIGA Cardiovascular Sciences, CHU Sart Tilman, Cardiology Department, University of Liège Hospital, Liège, Belgium.

Mai-Linh Nguyen Trung (ML)

GIGA Cardiovascular Sciences, CHU Sart Tilman, Cardiology Department, University of Liège Hospital, Liège, Belgium.

Pauline Danthine (P)

GIGA Cardiovascular Sciences, CHU Sart Tilman, Cardiology Department, University of Liège Hospital, Liège, Belgium.

Hélène Petitjean (H)

GIGA Cardiovascular Sciences, CHU Sart Tilman, Cardiology Department, University of Liège Hospital, Liège, Belgium.

Vito Domenico Bruno (VD)

Department of Minimally Invasive Cardiac Surgery, IRCCS Galeazzi-Sant'Ambrogio Hospital, Milan, Italy.

Christophe Martinez (C)

GIGA Cardiovascular Sciences, CHU Sart Tilman, Cardiology Department, University of Liège Hospital, Liège, Belgium.

Mathieu Lempereur (M)

GIGA Cardiovascular Sciences, CHU Sart Tilman, Cardiology Department, University of Liège Hospital, Liège, Belgium.

Marco Guazzi (M)

School of Medicine, Department of Biological Sciences, University of Milano, Milan, Italy.
Cardiology Division, San Paolo Hospital, Milan, Italy.

Samy Aghezzaf (S)

CHU Lille, Institut Pasteur de Lille, University Lille, Inserm, Lille, France.

Augustin Coisne (A)

CHU Lille, Institut Pasteur de Lille, University Lille, Inserm, Lille, France.
Cardiovascular Research Foundation, New York, NY, United States.

Cécile Oury (C)

GIGA Cardiovascular Sciences, CHU Sart Tilman, Cardiology Department, University of Liège Hospital, Liège, Belgium.

Raluca Dulgheru (R)

GIGA Cardiovascular Sciences, CHU Sart Tilman, Cardiology Department, University of Liège Hospital, Liège, Belgium.

Patrizio Lancellotti (P)

GIGA Cardiovascular Sciences, CHU Sart Tilman, Cardiology Department, University of Liège Hospital, Liège, Belgium.
Gruppo Villa Maria Care and Research, Maria Cecilia Hospital, Cotignola, and Anthea Hospital, Bari, Italy.

Classifications MeSH